Literature DB >> 10787038

Expression of the alpha and beta subunits of Ca2+/calmodulin kinase II in the cerebellum of jaundiced Gunn rats during development: a quantitative light microscopic analysis.

J W Conlee1, S M Shapiro, S B Churn.   

Abstract

The homozygous (jj) jaundiced Gunn rat model for hyperbilirubinemia displays pronounced cerebellar hypoplasia. To examine the cellular mechanisms involved in bilirubin toxicity, this study focused on the effect of hyperbilirubinemia on calcium/calmodulin-dependent kinase II (CaM kinase II). CaM kinase II is a neuronally enriched enzyme which performs several important functions. Immunohistochemical analysis of alternating serial sections were performed using monoclonal antibodies for the alpha and beta subunits of CaM kinase II. Measurements were made of the total numbers of stained cells in each of the deep cerebellar nuclei and of Purkinje and granule cell densities in cerebellar lobules II, VI, and IX. The beta subunit was present in Purkinje cells and deep cerebellar nuclei of both groups at all ages, but only granule cells which had migrated through the Purkinje cell layer showed staining for beta subunit; external granule cells were completely negative. Many Purkinje cells had degenerated in the older animals, and the percent of granule cells stained for beta subunit was significantly reduced. The alpha subunit was found exclusively in Purkinje cells, although its appearance was delayed in the jaundiced animals. Sulfadimethoxine was administered to some jj rats 24 h or 15 days prior to sacrifice to increase brain bilirubin concentration. Results showed that bilirubin exposure modulated both alpha and beta CaM kinase II subunit expression in selective neuronal populations, but sulfadimethoxine had no acute effect on enzyme immunoreactivity. Thus, developmental expression of the alpha and beta subunits of CaM kinase II was affected by chronic bilirubin exposure during early postnatal development of jaundiced Gunn rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787038     DOI: 10.1007/s004010051141

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  A mechanism underlying AMPA receptor trafficking during cerebellar long-term potentiation.

Authors:  Wataru Kakegawa; Michisuke Yuzaki
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-22       Impact factor: 11.205

Review 2.  Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Authors:  Jon F Watchko
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome).

Authors:  Rei Yasukawa; Tsuyoshi Miyaoka; Shoichi Mizuno; Takuji Inagaki; Jun Horiguchi; Kazushige Oda; Hajime Kitagaki
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

4.  Microglia-induced activation of non-canonical Wnt signaling aggravates neurodegeneration in demyelinating disorders.

Authors:  Takeshi Shimizu; Ron Smits; Kazuhiro Ikenaka
Journal:  Mol Cell Biol       Date:  2016-08-22       Impact factor: 4.272

Review 5.  Bilirubin Encephalopathy.

Authors:  Shuo Qian; Prateek Kumar; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2022-05-19       Impact factor: 5.081

6.  Distribution of CaMKIIα expression in the brain in vivo, studied by CaMKIIα-GFP mice.

Authors:  Xinjun Wang; Chunzhao Zhang; Gábor Szábo; Qian-Quan Sun
Journal:  Brain Res       Date:  2013-04-28       Impact factor: 3.252

Review 7.  Review of bilirubin neurotoxicity I: molecular biology and neuropathology of disease.

Authors:  Sean M Riordan; Steven M Shapiro
Journal:  Pediatr Res       Date:  2019-10-10       Impact factor: 3.756

8.  PTBP-dependent PSD-95 and CamKIIα alternative splicing in the lens.

Authors:  Peter Frederikse; Anoop Nandanoor; Chinnaswamy Kasinathan
Journal:  Mol Vis       Date:  2014-12-12       Impact factor: 2.367

Review 9.  CaMKIIβ in Neuronal Development and Plasticity: An Emerging Candidate in Brain Diseases.

Authors:  Olivier Nicole; Emilie Pacary
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.